How we see the development of clinical trials from the investigators' side?

István Bitter, Csilla Bolyós, Mónika Nagy, János Réthelyi, Pál Czobor

Research output: Contribution to journalArticle

Abstract

This is a discussion paper on research in clinical pharmacology in the field of psychiatry. In addition to other factors the decline in discovery and development of new drugs in the field of psychiatry and the developments and growing complexity in the field of clinical trial technology, including outsourcing and risk based monitoring, reduced the number of young clinical researchers interested in this important field. The challenges posed by the restructuring within the pharmacological industry - including digitalization - should induce changes in the structure and in the processes of clinical pharmacology research and in the training of clinical research staff members. The approval of esketamine nasal spray for treatment resistant depression by the FDA and the results of research with psychedelics call for more education and training in this specific field.

Original languageEnglish
Pages (from-to)393-402
Number of pages10
JournalPsychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata
Volume34
Issue number4
Publication statusPublished - Jan 1 2019

Fingerprint

Research Personnel
Clinical Trials
Clinical Pharmacology
Research
Psychiatry
Outsourced Services
Treatment-Resistant Depressive Disorder
Hallucinogens
Nasal Sprays
Industry
Pharmacology
Technology
Education
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

How we see the development of clinical trials from the investigators' side? / Bitter, István; Bolyós, Csilla; Nagy, Mónika; Réthelyi, János; Czobor, Pál.

In: Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata, Vol. 34, No. 4, 01.01.2019, p. 393-402.

Research output: Contribution to journalArticle

@article{a3abddd343124ab494998f0090f3d7f5,
title = "How we see the development of clinical trials from the investigators' side?",
abstract = "This is a discussion paper on research in clinical pharmacology in the field of psychiatry. In addition to other factors the decline in discovery and development of new drugs in the field of psychiatry and the developments and growing complexity in the field of clinical trial technology, including outsourcing and risk based monitoring, reduced the number of young clinical researchers interested in this important field. The challenges posed by the restructuring within the pharmacological industry - including digitalization - should induce changes in the structure and in the processes of clinical pharmacology research and in the training of clinical research staff members. The approval of esketamine nasal spray for treatment resistant depression by the FDA and the results of research with psychedelics call for more education and training in this specific field.",
author = "Istv{\'a}n Bitter and Csilla Boly{\'o}s and M{\'o}nika Nagy and J{\'a}nos R{\'e}thelyi and P{\'a}l Czobor",
year = "2019",
month = "1",
day = "1",
language = "English",
volume = "34",
pages = "393--402",
journal = "Psychiatria Hungarica",
issn = "0237-7896",
publisher = "Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata",
number = "4",

}

TY - JOUR

T1 - How we see the development of clinical trials from the investigators' side?

AU - Bitter, István

AU - Bolyós, Csilla

AU - Nagy, Mónika

AU - Réthelyi, János

AU - Czobor, Pál

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This is a discussion paper on research in clinical pharmacology in the field of psychiatry. In addition to other factors the decline in discovery and development of new drugs in the field of psychiatry and the developments and growing complexity in the field of clinical trial technology, including outsourcing and risk based monitoring, reduced the number of young clinical researchers interested in this important field. The challenges posed by the restructuring within the pharmacological industry - including digitalization - should induce changes in the structure and in the processes of clinical pharmacology research and in the training of clinical research staff members. The approval of esketamine nasal spray for treatment resistant depression by the FDA and the results of research with psychedelics call for more education and training in this specific field.

AB - This is a discussion paper on research in clinical pharmacology in the field of psychiatry. In addition to other factors the decline in discovery and development of new drugs in the field of psychiatry and the developments and growing complexity in the field of clinical trial technology, including outsourcing and risk based monitoring, reduced the number of young clinical researchers interested in this important field. The challenges posed by the restructuring within the pharmacological industry - including digitalization - should induce changes in the structure and in the processes of clinical pharmacology research and in the training of clinical research staff members. The approval of esketamine nasal spray for treatment resistant depression by the FDA and the results of research with psychedelics call for more education and training in this specific field.

UR - http://www.scopus.com/inward/record.url?scp=85075549926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075549926&partnerID=8YFLogxK

M3 - Article

C2 - 31767799

AN - SCOPUS:85075549926

VL - 34

SP - 393

EP - 402

JO - Psychiatria Hungarica

JF - Psychiatria Hungarica

SN - 0237-7896

IS - 4

ER -